Pharmaceutical

Alentis and PinotBio partner to develop claudin-1 oncol...

Under the agreement, Alentis has secured an exclusive option to in-license linke...

QCi and INmune Bio partner to study XPro in Alzheimer’s

The initial agreement marks the first commercial contract in the pharmaceutical ...

Zydus launches Season 3 of ‘Easiest Exam’ campaign to p...

The campaign will also feature oncologists sharing insights on early detection,...

VP inaugurates KAUMARACON-2026, launches digital initia...

Calls for scientific validation of Ayurveda, highlights child health as a natio...

Our next phase of growth focuses on deepening technolog...

MOVIN Express, through its specialised MOVIN Healthcare vertical is addressing ...

Indian pharmaceutical market records 17.1% growth in Se...

Strongest monthly growth in three years; 2QFY27 growth reaches 14.7 per cent Th...

Zydus Sunshine Lifesciences signs agreement to set up p...

The proposed facility in Horana involves a phased investment of over $20 millio...

Charles River partners with Magellan Stem Cells on cell...

The partnership focuses on biologics quality control as well as viral and releas...

Pfizer partners with Enodia Therapeutics in $500m drug ...

Under the partnership, Enodia Therapeutics will handle initial discovery work to...

From botox to algorithms: How AI is redefining cosmetic...

Dr Ashok Patel, Aesthetic Surgeon, Founder and Chief Medical Officer, Brillianc...

NIPER Raebareli, AstraZeneca India partner to expand cl...

The collaboration will assess and support 25 clinical trial sites across emergi...

ISCR, CHAKRA sign MoU to strengthen clinical research c...

The partnership will focus on GCP and ethics training, research governance, qua...

Biocon secures global settlement with Genentech for Peb...

The agreement sets licensed launch dates for Biocon’s pertuzumab biosimilar in ...

Godavari Biorefineries secures Mexican patent for antiv...

The patent covers compounds that inhibit V-ATPase and their use in the manufact...

China’s NMPA clears Foresee’s Camcevi 42 mg for prostat...

The company was informed of the decision by its domestic licensing partner, Chan...

Southern Research secures NIH funding for drug testing hub

The planned facility will focus on the development, validation, and adoption of ...